Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Cardiologist sues hospital | Catheter recall may result in shortage | AI's potential | Boosting surgery volumes

News You Need to Know Today
Cardiologist sues hospital | Catheter recall may result in shortage | AI's potential | Boosting surgery volumes
Tuesday, September 16, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Cardiac Surgery

Cardiologist sues hospital after he was allegedly let go for sharing safety concerns

The veteran interventional cardiologist claims he was pushed out after repeatedly asking for more coverage from cardiothoracic surgeons in addition to other improvements. The hospital, meanwhile, described the lawsuit as a “collection of false allegations."

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist sues hospital after he was allegedly let go for sharing safety concerns

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The veteran interventional cardiologist claims he was pushed out after repeatedly asking for more coverage from cardiothoracic surgeons in addition to other improvements. The hospital, meanwhile, described the lawsuit as a “collection of false allegations."
READ MORE >

Update: FDA announces new Class I recalls due to safety issue with Medtronic catheters

More than 100,000 surgical devices are included in these recalls, and there may be "limited product availability" in the months ahead. The FDA first warned the public about this issue in August. 

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

Update: FDA announces new Class I recalls due to safety issue with Medtronic catheters

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
More than 100,000 surgical devices are included in these recalls, and there may be "limited product availability" in the months ahead. The FDA first warned the public about this issue in August. 
READ MORE >

How interventional cardiologists can boost cardiac surgery volumes

Competition was once fierce between interventional cardiologists and cardiac surgeons, but that has changed over the years. "It is absolutely a partnership," one veteran surgeon told Cardiovascular Business. 

READ MORE >
John Puskas, MD, MSc, PhD., FACS, FACC, professor of surgery, and chief of cardiothoracic surgery at Emory University Hospital Midtown, explains how interventional cardiologists can play a role in increasing referrals for coronary artery bypass graft (CABG) surgery for patients who are best suited for the procedure, as opposed to percutaneous coronary intervention (PCI). As the heart team approach expands across cardiology, with surgeons and interventionalists making more decisions together.
Share on Twitter Share on Facebook Share on Linkedin

How interventional cardiologists can boost cardiac surgery volumes

Share on Twitter Share on Facebook Share on Linkedin
John Puskas, MD, MSc, PhD., FACS, FACC, professor of surgery, and chief of cardiothoracic surgery at Emory University Hospital Midtown, explains how interventional cardiologists can play a role in increasing referrals for coronary artery bypass graft (CABG) surgery for patients who are best suited for the procedure, as opposed to percutaneous coronary intervention (PCI). As the heart team approach expands across cardiology, with surgeons and interventionalists making more decisions together.
Competition was once fierce between interventional cardiologists and cardiac surgeons, but that has changed over the years. "It is absolutely a partnership," one veteran surgeon told Cardiovascular Business. 
READ MORE >

Heart surgeons see more potential in AI than colleagues from other fields

Cardiac surgeons see significant value in AI's ability to assist clinicians with administrative tasks and patient selection. When it comes to making clinical decisions, however, there is still a certain amount of skepticism. 

READ MORE >
AI healthcare doctor surgery procedure artificial intelligence
Share on Twitter Share on Facebook Share on Linkedin

Heart surgeons see more potential in AI than colleagues from other fields

Share on Twitter Share on Facebook Share on Linkedin
AI healthcare doctor surgery procedure artificial intelligence
Cardiac surgeons see significant value in AI's ability to assist clinicians with administrative tasks and patient selection. When it comes to making clinical decisions, however, there is still a certain amount of skepticism. 
READ MORE >

First study of its kind to focus on new therapy for hypoplastic left heart syndrome

The new trial represents a potential breakthrough in the treatment of one of the most devastating congenital heart defects.

READ MORE >
Joshua M. Hare, MD, FACC, FAHA, a professor of medicine, molecular and cellular pharmacology, and biomedical engineering, director of regenerative medicine, and director of the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami, and co-founder and chief science officer for the stem cell start-up Longeveron, explains the FDA trial for laromestrocel (Lomecel-B) to treat hypoplastic left heart syndrome (HLHS).
Share on Twitter Share on Facebook Share on Linkedin

First study of its kind to focus on new therapy for hypoplastic left heart syndrome

Share on Twitter Share on Facebook Share on Linkedin
Joshua M. Hare, MD, FACC, FAHA, a professor of medicine, molecular and cellular pharmacology, and biomedical engineering, director of regenerative medicine, and director of the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami, and co-founder and chief science officer for the stem cell start-up Longeveron, explains the FDA trial for laromestrocel (Lomecel-B) to treat hypoplastic left heart syndrome (HLHS).
The new trial represents a potential breakthrough in the treatment of one of the most devastating congenital heart defects.
READ MORE >

3D echo guidance seeing increasing use in congenital heart surgery

Pei-Ni Jone, MD, FASE, director, echocardiography laboratory, Lurie Children’s Hospital Heart Center, member of the American Society of Echocardiography (ASE) Board, explains how 3D echo is being used to better plan, guide and follow up in congenital cardiac surgery.

READ MORE >
Pei-Ni Jone, MD, FASE, director, echocardiography laboratory, Lurie Children’s Hospital Heart Center, professor of pediatric cardiology, Northwestern University Feinberg School of Medicine, member of the American Society of Echocardiography (ASE) Board, and the chair of the ASE Pediatric and Congenital Heart Disease Council Steering Committee, explains how 3D echo is being used to better plan, guide and followup in congenital cardiac surgery.
Share on Twitter Share on Facebook Share on Linkedin

3D echo guidance seeing increasing use in congenital heart surgery

Share on Twitter Share on Facebook Share on Linkedin
Pei-Ni Jone, MD, FASE, director, echocardiography laboratory, Lurie Children’s Hospital Heart Center, professor of pediatric cardiology, Northwestern University Feinberg School of Medicine, member of the American Society of Echocardiography (ASE) Board, and the chair of the ASE Pediatric and Congenital Heart Disease Council Steering Committee, explains how 3D echo is being used to better plan, guide and followup in congenital cardiac surgery.
Pei-Ni Jone, MD, FASE, director, echocardiography laboratory, Lurie Children’s Hospital Heart Center, member of the American Society of Echocardiography (ASE) Board, explains how 3D echo is being used to better plan, guide and follow up in congenital cardiac surgery.
READ MORE >

Advanced risk score predicts long-term survival after mitral valve surgery

The Society of Thoracic Surgeons Risk Calculator is more traditionally used to calculate short-term risks, but this single-center analysis suggests it can also anticipate issues well into the future.

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

Advanced risk score predicts long-term survival after mitral valve surgery

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
The Society of Thoracic Surgeons Risk Calculator is more traditionally used to calculate short-term risks, but this single-center analysis suggests it can also anticipate issues well into the future.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Heart pump accessories recalled | Is it time for universal Lp(a) screening? | Long-term survival after mitral valve surgery
Air embolism risk linked to 17 deaths | IVL complications are rare | 'Encouraging' PCI data | Medicare covers TriClip
Palliative care & heart failure | IVL for mitral valve disease | New coronary sinus reducer data | $32M for LAAO tech
FDA details device recalls | A new technique for robotic AVR | CABG or PCI? | Surgeon pay takes a hit
AI fueling more & more cardiology tech | Heartflow rings opening bell | High costs may limit access | ACC takes on pericarditis
The best heart hospitals in the United States | Key takeaways from new LAAO guidelines | Choosing between CABG & PCI
How cardiologists can boost surgery volumes | Spreading the word about CKM syndrome | Fitness trackers & cardiovascular health

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …60
    • Page 61
    • Page 62
    • Page 63
    • Current page 64
    • Page 65
    • Page 66
    • Page 67
    • Page 68 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup